skip to main content

News Archive

Date: 09/21/2017
A nanoparticle-assisted optical imaging technique could one day enable doctors to read those clues in real time, providing a non-invasive precision medicine approach that could match treatment to individual tumors.
Date: 09/21/2017
University of Michigan Radiation Oncologists are attending ASTRO. Issam El Naqa, Robert Dess, Yi Luo, Yue Cao and Payal Soni will be presenting today.
Date: 09/21/2017
University of Michigan Radiation Oncologists are attending ASTRO. Latifa Bazzi, Payal Soni, Benjamin Rosen, Sudharsan Srinivasan, Whitney Hitchcock, Daniel Spratt, Peter Hawkins, Michelle Mierzwa ad William Jackson will be presenting today.
Date: 09/21/2017
University of Michigan Radiation Oncologists are attending ASTRO. Reshma Jagsi, Martha Matuszak, Robert Dess and William Jackson will be presenting today.
Date: 09/20/2017
University of Michigan Radiation Oncologists are attending ASTRO. Dawn Owen, Kyle Cuneo, Payal Soni, Dean Shumway, Michael Green, Peter Hawkins, Robert Dress, WIlliam Jackson, Shuang Zhao and Corey Spears will be presenting today.
Date: 09/01/2017
Cancer cells obtained from a blood test may be able to predict how early-stage lung cancer patients will fare, a team from the University of Michigan has shown. This information could be used to determine which patients are most likely to benefit from additional therapies to head off the spread of the cancer to other areas of the body.
Date: 09/01/2017
Author: Rosemary Clandos  Media contact: Nicole Fawcett, 734-764-2220 |  Patients may contact Cancer AnswerLine™, &
Date: 08/28/2017
Individual acupressure points linked to specific centers in the brain can offer targeted relief for breast cancer patients with persistent fatigue, according to a new neuroimaging study.
Date: 08/24/2017
Reuters reports on a study published in European Urology that shows that black men in America with medium- and high-risk prostate tumors are less likely to get aggressive treatment than white men are.
Date: 08/24/2017
An experimental drug combined with the traditional chemotherapy drug cisplatin, when used in mice, destroyed a rare form of salivary gland tumor and prevented a recurrence within 300 days, a University of Michigan study found.

Pages